GET DAILY SIGNALSMedical Properties Trust (MPT) Stock Falls -31.6% Over 30 Days as Tenant and Leverage Issues Weigh
Key Takeaways
- Medical Properties Trust (MPT) fell roughly 31.6% over the past 30 days, sliding from a $3.51 close on September 29, 2026 to about $2.40 in late-October trading.
- The decline extended a longer downtrend, with the stock down close to 49.5% over the last quarter from a $4.75 close in late July 2026.
- Third-quarter 2026 results showed a return to net income but weaker normalized funds from operations (FFO), which declined to $0.11 per share from $0.13 a year earlier.
- Ongoing tenant credit issues, high short interest, and a persistently leveraged balance sheet remain central concerns for investors.
- The company completed asset sales generating roughly $680 million in cash proceeds and a private offering of about $2.4 billion in secured notes during the quarter to reduce debt.
Company Background and Market Position
Medical Properties Trust, Inc. is a self-advised real estate investment trust (REIT) focused on hospital real estate. The company acquires and develops healthcare facilities and leases them to operators under long-term net leases, while also providing mortgage loans secured by real estate. MPT is one of the world's largest non-governmental owners of hospital beds, with approximately 373 facilities and 38,000 licensed beds across nine countries and three continents. The company changed its ticker symbol to MPT on the New York Stock Exchange effective February 2, 2026, as part of a broader brand refresh. Investors follow the stock closely because its portfolio and financing model are sensitive to tenant health, reimbursement trends, interest rates, and balance-sheet leverage. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Recent Stock Performance: 30 Days Versus the Quarter
Over the last 30 days, MPT declined approximately 31.6%, moving from a closing price of $3.51 on September 29, 2026 to around $2.40 in late-October trading. The selling accelerated through October, with the stock breaking below the $3.00 level and then the $2.80 level in the final stretch of the period.
The quarterly picture is even steeper. From a close of $4.75 in late July 2026, the stock has fallen close to 49.5%, reflecting a sustained downward trend rather than a single isolated event. The one-month decline is therefore part of a broader multi-month repricing that has weighed on the shares throughout the third quarter and into the fourth.
Factors Behind the Recent 30-Day Decline
The recent decline was driven by a combination of fundamentals, sentiment, and positioning. On October 29, 2026, MPT reported third-quarter net income of $202.1 million, or $0.34 per share, compared with a net loss of $77.5 million a year earlier, while total revenue rose to $250.1 million from $237.5 million. However, normalized funds from operations declined to $63.8 million, or $0.11 per share, from $77.2 million, or $0.13 per share, a year earlier, and revenue came in below some consensus estimates.
Investor concerns around tenant credit quality also remained in focus. Management disclosed an agreement with U.K. behavioral-health tenant Priory to reduce annual rental obligations by approximately 18%, with rent recovery tied to patient volumes, while also addressing operational changes at the HSA hospital group. Elevated short interest has likewise been a persistent overhang, with MPT ranking among the most heavily shorted REITs. From what I see, this combination continues to pressure sentiment.
Offsetting some of this pressure, the company completed asset sales that generated approximately $680 million in cash proceeds during the quarter and finalized a private offering of about $2.4 billion of secured notes, with proceeds used to repay near-term debt and strengthen liquidity. MPT also paid a regular quarterly dividend of $0.09 per share in October.
Quarterly Trends and Company Actions
The quarterly decline reflects a larger narrative of deleveraging, tenant transition, and lingering market skepticism. Throughout the period, MPT prioritized asset sales and debt refinancing to address maturities and reduce leverage, while working to stabilize operators following the earlier bankruptcies of large tenants Steward Health Care and Prospect Medical Holdings. International exposure, particularly in the U.K. healthcare market, introduced additional uncertainty tied to budget constraints and reimbursement pressures.
At the same time, management pointed to progress in cash rent collection and reaffirmed confidence in the business model, with a portfolio spanning more than 50 operators globally. Despite these efforts, the market continued to discount the shares, and MPT has underperformed the broader market by a wide margin so far in 2026.
Key Factors Investors Should Watch Next
Looking ahead, investors are likely to focus on several factors. Tenant cash collections and rent coverage across the hospital portfolio, including the performance of recently transitioned operators, will be central to the FFO outlook. Debt refinancing progress, asset-sale execution, and the trajectory of the balance sheet will also influence sentiment. Macroeconomic inputs such as interest rates, healthcare reimbursement trends, and conditions in international markets, particularly the U.K., remain key variables. Finally, short interest and institutional positioning could contribute to continued volatility. These are factors to monitor, not a basis for any investment decision. I’m watching this closely as the situation develops.
AI Tools in Portfolio Monitoring
In my own analysis, I regularly review Tickeron’s Trending AI Robots to observe how automated systems are positioning in names like this one. The platform highlights top-performing bots across strategies and timeframes, offering a useful complement to traditional fundamental work when markets remain volatile.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MPT in upward trend: price may jump up because it broke its lower Bollinger Band on October 19, 2026
MPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 42 cases where MPT's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MPT's RSI Oscillator exited the oversold zone, 22 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 50%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MPT as a result. In 63 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for MPT turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 34 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MPT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for MPT entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.365) is normal, around the industry mean (3.066). MPT has a moderately low P/E Ratio (-55.000) as compared to the industry average of (27.232). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). MPT's Dividend Yield (0.131) is considerably higher than the industry average of (0.048). P/S Ratio (1.994) is also within normal values, averaging (6.013).
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. MPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PublishingBooksMagazines
Advertisement